Catalyst Wire Dossier Catalyst Wire Dossier

REFRESH®

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REFRESH®, covering 2006-08-22 to 2008-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes [Phase 4]

See pricing